Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer

Cancer Research

Volumn 74, Issue 23, 2014, Pages 6890-6902

  Hu, Ye ^a   Wang, Jilin ^a   Qian, Jin ^b   Kong, Xuan ^a   Tang, Jieting ^a   Wang, Yingchao ^a   Chen, Haoyan ^b   Hong, Jie ^b   Zou, Weiping ^c   Chen, Yingxuan ^a   Xu, Jie ^a,d   Fang, Jing Yuan ^a  

^a School of Medicine   (China)

^b BEIJING HOSPITAL   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC ADENOCARCINOMA PREDICTIVE LONG INTERGENIC NONCODING RNA; HERMES ANTIGEN; LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA; MICRORNA 211 3P; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; RNA;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; STOMACH CANCER; CELL MOTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; PATHOLOGY; PROCEDURES; PROGNOSIS; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

ANTIGENS, CD44; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PROGNOSIS; RNA, LONG NONCODING; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS;

EID: 84917705634     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-0686     Document Type: Article

References (35)

1. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-46.
2. Luebeck EG, Curtius K, Jeon J, Hazelton WD. Impact of tumor progression on cancer incidence curves. Cancer Res 2013;73: 1086-96.
3. Kong X, Qian J, Chen LS, Wang YC, Wang JL, Chen H, et al. Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness. J Natl Cancer Inst 2013;105:1738-49.
4. Ma Q, Reeves JH, Liberles DA, Yu L, Chang Z, Zhao J, et al. A phylogenetic model for understanding the effect of gene duplication on cancer progression. Nucleic Acids Res 2014;42:2870-8.
5. Dwivedi GR, Sharma E, Rao DN. Helicobacter pylori DprA alleviates restriction barrier for incoming DNA. Nucleic Acids Res 2013;41: 3274-88.
6. Rifkin DB, Ota M, Horiguchi M, Fang V, Shibahara K, Kadota K, et al. Genetic suppression of in fl ammation blocks the tumor-promoting effects of TGF-beta in gastric tissue. Cancer Res 2014;74: 2642-51.
7. Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang P, et al. CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res 2014;74:520-31.
8. Qian J, Kong X, Deng N, Tan P, Chen H, Wang J, et al. OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer. Gut. 2014 Apr 9. [Epub ahead of print].
9. Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancermolecular and clinical dimensions. Nat Rev Clin Oncol 2013;10: 643-55.
10. Keller C, Kulasegaran-Shylini R, Shimada Y, Hotz HR, Buhler M. Noncoding RNAs prevent spreading of a repressive histone mark. Nat Struct Mol Biol 2013;20:994-1000.
11. Xie C, Yuan J, Li H, Li M, Zhao G, Bu D, et al. NONCODEv4: exploring the world of long non-coding RNA genes. Nucleic Acids Res 2014;42: D98-103.
12. Lv J, Liu H, Huang Z, Su J, He H, Xiu Y, et al. Long non-coding RNA identification over mouse brain development by integrative modeling of chromatin and genomic features. Nucleic Acids Res 2013;41: 10044-61.
13. Sigova AA, Mullen AC, Molinie B, Gupta S, Orlando DA, Guenther MG, et al. Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci U S A 2013;110:2876-81.
14. Yang X, Song JH, Cheng Y, Wu W, Bhagat T, Yu Y, et al. Long noncoding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 2014;63:881-90.
15. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 2013;41:4976-87.
16. Guo X, Gao L, Liao Q, Xiao H, Ma X, Yang X, et al. Long non-coding RNAs function annotation: a global prediction method based on bicolored networks. Nucleic Acids Res 2013;41:e35.
17. Li Z, Chao TC, Chang KY, Lin N, Patil VS, Shimizu C, et al. The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A 2014;111: 1002-7.
18. Kerin T, Ramanathan A, Rivas K, Grepo N, Coetzee GA, Campbell DB. A noncoding RNA antisense to moesin at 5p14.1 in autism. Sci Transl Med 2012;4:128ra40.
19. Guil S, Esteller M. Cis-acting noncoding RNAs: friends and foes. Nat Struct Mol Biol 2012;19:1068-75.
20. Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M, et al. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol 2013;20:908-13.
21. Li Q, Su Z, Xu X, Liu G, Song X, Wang R, et al. AS1DHRS4, a head-to-head natural antisense transcript, silences the DHRS4 gene cluster in cis and trans. Proc Natl Acad Sci U S A 2012;109: 14110-5.
22. Passon DM, Lee M, Rackham O, Stanley WA, Sadowska A, Filipovska A, et al. Structure of the heterodimer of human NONO and paraspeckle protein component 1 and analysis of its role in subnuclear body formation. Proc Natl Acad Sci U S A 2012;109: 4846-50.
23. Li L, Liu B, Wapinski OL, Tsai MC, Qu K, Zhang J, et al. Targeted disruption of hotair leads to homeotic transformation and gene derepression. Cell Rep 2013;5:3-12.
24. Endo H, Shiroki T, Nakagawa T, Yokoyama M, Tamai K, Yamanami H, et al. Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS ONE 2013;8:e77070.
25. Cao WJ, Wu HL, He BS, Zhang YS, Zhang ZY. Analysis of long noncoding RNA expression profiles in gastric cancer. World J Gastroenterol 2013;19:3658-64.
26. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002;99:6567-72.
27. DoPM, Varanasi L, Fan S, Li C, Kubacka I,Newman V, et al. Mutant p53 cooperates with ETS2 to promote etoposide resistance. Genes Dev 2012;26:830-45.
28. Shimada S, Mimata A, Sekine M, Mogushi K, AkiyamaY, Fukamachi H, et al. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut 2012;61:344-53.
29. Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, et al. STAT3 and STAT1 mediate IL-11-dependent and inflammationassociated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008;118:1727-38.
30. Chen P, Zhao D, Sun Y, Huang L, Zhang S, Yuan Y. Protein inhibitor of activated STAT-1 is downregulated in gastric cancer tissue and involved in cell metastasis. Oncol Rep 2012;28:2149-55.
31. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-50.
32. Muckstein U, Tafer H, Hackermuller J, Bernhart SH, Stadler PF, Hofacker IL. Thermodynamics of RNA-RNA binding. Bioinformatics 2006;22:1177-82.
33. Deng N, Goh LK, Wang H, Das K, Tao J, Tan IB, et al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 2012;61:673-84.
34. Xu J, Reumers J, Couceiro JR, De Smet F, Gallardo R, Rudyak S, et al. Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat Chem Biol 2011;7:285-95.
35. Xu J, Zhou X, Wang J, Li Z, Kong X, Qian J, et al. RhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domain. Cell Rep 2013;3:1526-38.